Dr. Gregory A. Otterson

Get to Know Dr. Gregory A. Otterson

Now retired, Dr. Gregory A. Otterson was co-director of the Thoracic Oncology Program for the Division of Medical Oncology at the Ohio State University Comprehensive Cancer Center. Dr. Otterson was been a leader in development of novel targeted treatments. 

His clinical experience and research led to therapeutic advancements with malignant mesothelioma, lung cancer, thymus cancers and pleural disease.

Treating both early-stage and advanced disease, Otterson had earned his role as a guidelines panelist for the National Comprehensive Cancer Network. He also served as clinical director of the Thoracic Oncology Disease Specific Research Group and professor of internal medicine at Ohio State.

Otterson was recently ranked among the top 10% of physicians in the nation for patient satisfaction, a reflection of his dedication to helping others in any way he can.

“Every day I go to the clinic, the thing that moves me tremendously is the individual and his family sitting in front of me, asking for help. Whether I can help them by a molecular targeted agent, or by a new clinical trial, or by supportive measures — sometimes all three of those – are really what’s appropriate,” he said. “That’s what floats my boat and hopefully moves things forward, so we can get better next year.”

Earlier in his career, Otterson was part of a phase II clinical trial that explored the effectiveness of capecitabine for patients with mesothelioma. He worked closely with specialists such as surgeons, pathologists, radiologists and pulmonologists in a multidisciplinary approach, to make sure patients are getting the best care possible.

Specialties of Dr. Gregory A. Otterson, M.D.

Dr. Gregory A. Otterson’s Experience and Medical Education

Awards and Certifications

Publications of Dr. Gregory A. Otterson